Também conhecido como
24-hour urine copper
Total copper
Non-ceruloplasmin-bound copper
Free copper
Hepatic copper
Nome formal
Copper (24-hour urine, total and free blood, and hepatic)
Este artigo foi revisto pela última vez em
Este artigo foi modificado pela última vez em 10 de Julho de 2017.
At a Glance
Why Get Tested?
To measure the amount of copper in the blood, urine, or liver; to help diagnose and monitor Wilson’s disease; sometimes to identify copper deficiencies and excesses
When To Get Tested?
When you have jaundice, fatigue, abdominal pain, behavioral changes, tremors, or other symptoms that your doctor thinks may be due to Wilson’s disease or, rarely, to copper deficiency or excess; at intervals when you are being treated for a copper-related condition
Sample Required?
A blood sample drawn from a vein in your arm and/or a 24-hour urine sample; sometimes a liver biopsy sample
Test Preparation Needed?
What is being tested?
This test measures the amount of copper in the blood, urine, or liver (hepatic). Copper is an essential mineral that the body incorporates into enzymes. These enzymes play a role in the regulation of iron metabolism, formation of connective tissue, energy production at the cellular level, the creation of melanin, and the function of the nervous system and brain.

Copper is found in many foods including nuts, chocolate, mushrooms, shellfish, whole grains, dried fruits, and liver. Drinking water may acquire copper as it flows through copper pipes, and food may acquire it when people cook or serve food in copper dishes. Normally, the body absorbs copper from the intestines, makes it nontoxic by binding it to a protein, and transports it to the liver. The liver stores some of the copper and binds most of the rest to a protein called apoceruloplasmin that, when copper is attached, becomes the enzyme ceruloplasmin. About 95% of the copper in the blood is bound to ceruloplasmin. The liver excretes excess copper into the bile and it is removed from the body in the stool. Some copper is also excreted in the urine.

Both excesses and deficiencies of copper are rare. Wilson’s disease, an inherited disorder, can lead to excess storage of copper in the liver, brain, and other organs. This can cause tissue damage and signs and symptoms such as:

  • anemia
  • nausea, abdominal pain
  • jaundice
  • fatigue
  • behavioral changes
  • tremors
  • difficulty walking and/or swallowing
  • dystonia
  • If the kidneys are involved, then urine production may be decreased or absent. Some of these symptoms may also be seen with copper poisoning that is due to acute or chronic environmental exposure to copper or due to conditions such as liver disease or obstructions that prevent or inhibit copper metabolism and excretion.

    Copper deficiencies may occasionally occur in patients who have conditions associated with severe malabsorption, such as cystic fibrosis and celiac disease, and in infants exclusively fed cow-milk formulas. Symptoms may include neutropenia, osteoporosis, and microcytic anemia. A rare X-linked genetic condition called Menkes kinky hair syndrome leads to copper deficiencies in the brain and liver of affected infants. The disease, which affects primarily males, is associated with seizures, delayed development, abnormal artery development in the brain, and unusual gray brittle kinky hair.

    How is the sample collected for testing?

    A blood sample is obtained by inserting a needle into a vein in the arm and/or a 24-hour urine sample is collected. Sometimes a doctor performs a liver biopsy.

    Is any test preparation needed to ensure the quality of the sample?

    No test preparation is needed.
    Accordion Title
    Common Questions
    • How is it used?
      Copper testing is primarily ordered to help diagnose Wilson’s disease. If a doctor suspects Wilson’s, then he would typically order a total and/or free (unbound) blood copper test along with a ceruloplasmin level. If these tests are abnormal or equivocal, then they may be followed by a 24-hour urine copper test to measure copper excretion and a hepatic (liver) copper test to evaluate copper storage. Genetic testing may also be performed to detect mutations in the ATP7B gene if Wilson’s disease is suspected. However, these tests have limited availability and are usually performed in special reference or research laboratories.

      If a doctor suspects copper toxicity, copper deficiency, or a disorder that is inhibiting copper metabolism, then he may order blood and/or urine copper tests along with ceruloplasmin to help evaluate the patient’s condition. One or more copper tests may be ordered to help monitor the effectiveness of treatment for Wilson’s disease, copper excess, or copper deficiency.

    • When is it ordered?
      One or more copper tests are ordered along with ceruloplasmin when someone has signs and symptoms that a doctor suspects may be due to Wilson’s disease, excess copper storage, copper poisoning, or due to a copper deficiency. These signs and symptoms may include:

    • anemia
    • nausea, abdominal pain
    • jaundice
    • fatigue
    • behavioral changes
    • tremors
    • difficulty walking and/or swallowing
    • dystonia
    • One or more of the copper tests may be ordered periodically when monitoring is recommended.

      A hepatic copper test may be ordered to further investigate copper storage when copper and ceruloplasmin results are abnormal or equivocal.

  • What does the test result mean?
    Copper test results must be evaluated in context and are usually compared to ceruloplasmin levels. Abnormal copper results are not diagnostic of a specific condition; they indicate the need for further investigation. Interpretation can be complicated by the fact that ceruloplasmin is an acute phase reactant – it may be elevated whenever inflammation or severe infections are present. Both ceruloplasmin and copper are also increased during pregnancy and with estrogen and oral contraceptive use.

    Test results may include:

  • Low blood copper concentrations along with increased urine copper levels, low ceruloplasmin levels, and increased hepatic copper are typically seen with Wilson’s disease.
  • Increased blood and urine copper concentrations and normal or increased ceruloplasmin levels may indicate exposure to excess copper or may be associated with conditions that decrease copper excretion – such as liver disease. Increased hepatic copper may be present with chronic conditions.
  • Decreased blood and urine copper concentrations and decreased ceruloplasmin may indicate a copper deficiency.
  • A normal hepatic copper test may indicate that copper metabolism is functioning properly or that the distribution of copper in the patient’s liver is uneven and the sample is not representative of the person’s condition.
  • If a patient is being treated for excess copper storage with chelators, then his 24-hour urine copper levels may be high until body copper stores decrease. Eventually, blood copper and 24-hour urine copper concentrations should normalize.

    If someone is being treated for a condition related to copper deficiency and his ceruloplasmin and total copper concentrations begin to rise, then the condition is likely responding to the treatment.

  • Is there anything else I should know?
    Medications such as carbamazepine and phenobarbital can increase blood copper levels. They may also be elevated with rheumatoid arthritis and with some cancers, and decreased with a variety of conditions associated with malabsorption, such as cystic fibrosis.

    Total serum copper concentrations are normally low at birth, rise over the next few years, peak, and then decline slightly to a relatively stable level.

    Care must be taken, especially with a 24-hour urine sample, not to contaminate the sample with an external source of copper. Talk to your doctor and/or the laboratory that will perform your test about necessary precautions. If a urine or blood copper test result is higher than the doctor expects, then he may have you repeat the test to confirm the findings.

  • Should everyone’s copper metabolism be evaluated?
    General screening for copper concentrations is not recommended or necessary. Many people with conditions not associated with copper, such as people with infections or inflammation, may have temporarily increased concentrations.
  • Can I choose either a blood (total or free) or urine copper test?
    These tests provide complementary information. It is up to you and your doctor to determine which tests are necessary to evaluate your condition.
  • What happens if I am exposed to toxic amounts of copper?
    Copper poisoning can cause vomiting and diarrhea and, in some cases, can lead to liver and kidney damage. You should talk to your doctor if you think that you have been exposed.
  • Should I be taking copper supplements or trying to get more copper in my diet?
    In most cases, a regular diet satisfies the body’s requirements for copper. Talk to your doctor before taking any supplements or changing your diet.
  • View Sources
    Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC. Bankson, D. Chapter 35, Vitamins and Trace Elements: Assessment of Micronutrient Status through Laboratory Testing. Pp. 399 – 410.

    Wu, A. (2006). Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders Elsevier, St. Louis, Missouri. Pp. 292-295.

    Alexander, D. (2006 March 2, Updated). 24-hour urine Copper/Cu [11 paragraphs]. MedlinePlus Medical Encyclopedia [On-line information]. Accessed on: 7/21/07. Available FTP: http://www.nlm.nih.gov/medlineplus/ency/article/003604.htm

    McGee, W. (2007 March 2, Updated). Copper in diet [10 paragraphs]. MedlinePlus Medical Encyclopedia [On-line information]. Accessed on: 7/25/07. Available FTP: http://www.nlm.nih.gov/medlineplus/ency/article/002419.htm

    Perez, E. (2006 October 23, Updated). Copper poisoning [12 paragraphs]. MedlinePlus Medical Encyclopedia [On-line information]. Accessed on: 7/25/07. Available FTP: http://www.nlm.nih.gov/medlineplus/ency/article/002496.htm

    (2004). Copper [23 paragraphs]. ATSDR Division of Toxicology ToxFAQs [On-line information]. Accessed on: 7/25/07. Available FTP: http://www.atsdr.cdc.gov/tfacts132.html

    (2007 February 13, Updated). Menkes Disease Information Page [4 paragraphs]. NINDS [On-line information]. Accessed on: 7/25/07. Available FTP: http://www.ninds.nih.gov/disorders/menkes/menkes.htm

    (2007 February 14). Zellweger Syndrome Information Page [4 paragraphs]. NINDS [On-line information]. Accessed on: 7/25/07. Available FTP: http://www.ninds.nih.gov/disorders/zellweger/zellweger.htm

    Thomas, Clayton L., Editor (1997). Taber’s Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition]. Pp. 441.

    Copper [11 paragraphs]. Merck Manual of Medical Information – Second Home Edition [On-line information]. Accessed on: 7/17/07. Available FTP: http://www.merck.com/mmhe/print/sec12/ch155/ch155c.html

    Das, S. and Ray, K. (2006 October 13). Wilson’s Disease: An Update [44 paragraphs]. Medscape from Nature Clinical Practice Neurology [On-line information]. Accessed on: 7/27/07. Available FTP: http://www.medscape.com/viewarticle/543866

    Turnlund, J. (2007 July, Reviewed). Copper [32 paragraphs]. Linus Pauling Institute Micronutrient Research for Optimum Health, Micronutrient Information Center, Oregon State University [On-line information]. Accessed on: 9/16/07. Available FTP: http://lpi.oregonstate.edu/infocenter/minerals/copper/

    (2006 August 1). Copper [48 paragraphs]. MedlinePlus Health Information, Herbs and Supplements [On-line information]. Accessed on: 9/16/07. Available FTP: http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-copper.html

    Barnes, N. et. al. (2005). The copper-transporting ATPases, menkes and wilson disease proteins, have distinct roles in adult and developing cerebellum. [1 paragraph]. Medscape from J Biol Chem. 2005; 280(10): 9640-5 (ISSN: 0021-9258) [On-line abstract]. Accessed on: 9/16/07. Available FTP: http://www.medscape.com/medline/abstract/15634671?src=emed_ckb_ref_0

    Shim, H. and Harris, Z. L. (2003 May). Supplement: 11th International Symposium on Trace Elements in Man and Animals, Genetic Defects in Copper Metabolism [14 paragraphs]. J. Nutr. 133: 1527S-1531S [On-line journal article]. Accessed on: 9/16/07. Available FTP: http://jn.nutrition.org/cgi/content/full/133/5/1527S